본문 바로가기
KERD
논문KCI 등재

A concise review of human brain methylome during aging and neurodegenerative diseases

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

DNA methylation at CpG sites is an essential epigenetic mark that regulates gene expression during mammalian development and diseases. Methylome refers to the entire set of methylation modifications present in the whole genome. Over the last several years, an increasing number of reports on brain DNA methylome reported the association between aberrant methylation and the abnormalities in the expression of critical genes known to have critical roles during aging and neurodegenerative diseases. Consequently, the role of methylation in understanding neurodegenerative diseases has been under focus. This review outlines the current knowledge of the human brain DNA methylomes during aging and neurodegenerative diseases. We describe the differentially methylated genes from fetal stage to old age and their biological functions. Additionally, we summarize the key aspects and methylated genes identified from brain methylome studies on neurodegenerative diseases. The brain methylome studies could provide a basis for studying the functional aspects of neurodegenerative diseases.

Abstract

DNA methylation at CpG sites is an essential epigenetic mark that regulates gene expression during mammalian development and diseases. Methylome refers to the entire set of methylation modifications present in the whole genome. Over the last several years, an increasing number of reports on brain DNA methylome reported the association between aberrant methylation and the abnormalities in the expression of critical genes known to have critical roles during aging and neurodegenerative diseases. Consequently, the role of methylation in understanding neurodegenerative diseases has been under focus. This review outlines the current knowledge of the human brain DNA methylomes during aging and neurodegenerative diseases. We describe the differentially methylated genes from fetal stage to old age and their biological functions. Additionally, we summarize the key aspects and methylated genes identified from brain methylome studies on neurodegenerative diseases. The brain methylome studies could provide a basis for studying the functional aspects of neurodegenerative diseases.

참고문헌 (98)

  1. Wyatt G, "Recognition and estimation of 5-methylcytosine in nucleic acids", Biochem J, 48, pp.581~ (1951)
  2. Hotchkiss RD, "The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography", J Biol Chem, 175, pp.315~332 (1948)
  3. Bird AP, "DNA methylation and the frequency of CpG in animal DNA", Nucleic Acids Res, 8, pp.1499~1504 (1980)
  4. Illingworth RS, "Orphan CpG islands identify numerous conserved promoters in the mammalian genome", PLoS Genet, 6, pp.e1001134~ (2010)
  5. Ladd-Acosta C, "DNA methylation signatures within the human brain", Am J Hum Genet, 81, pp.1304~1315 (2007)
  6. Siegmund KD, "DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons", PLoS One, 2, pp.e895~ (2007)
  7. Boyes J, "Repression of genes by DNA methylation depends on CpG density and promoter strength : evidence for involvement of a methyl‐CpG binding protein", EMBO J, 11, pp.327~333 (1992)
  8. Hsieh CL, "Dependence of transcriptional repression on CpG methylation density", Mol Cell Biol, 14, pp.5487~5494 (1994)
  9. Laurent L, "Dynamic changes in the human methylome during differentiation", Genome Res, 20, pp.320~331 (2010)
  10. Lister R, "Human DNA methylomes at base resolution show widespread epigenomic differences", Nature, 462, pp.315~ (2009)
  11. Rauch TA, "A human B cell methylome at 100− base pair resolution", Proc Natl Acad Sci U S A, 106, pp.671~678 (2009)
  12. Nan X, "Transcriptional repression by the methyl-CpG-binding protein MeCP2involves a histone deacetylase complex", Nature, 393, pp.386~ (1998)
  13. Domcke S, "Competition between DNA methylation and transcription factors determines binding of NRF1", Nature, 528, pp.575~ (2015)
  14. Gartler SM, "Mammalian X-chromosome inactivation", Annu Rev Genet, 17, pp.155~190 (1983)
  15. Reik W, "Genomic imprinting determines methylation of parental alleles in transgenic mice", Nature, 328, pp.248~ (1987)
  16. Swain JL, "Parental legacy determines methylation and expression of an autosomal transgene : a molecular mechanism for parental imprinting", Cell, 50, pp.719~727 (1987)
  17. Day JJ, "DNA methylation and memory formation", Nat Neurosci, 13, pp.1319~ (2010)
  18. Counts JL, "Alterations in DNA methylation may play a variety of roles in carcinogenesis", Cell, 83, pp.13~15 (1995)
  19. Jähner D, "De novo methylation and expression of retroviral genomes during mouse embryogenesis", Nature, 298, pp.623~ (1982)
  20. Walsh CP, "Transcription of IAP endogenous retroviruses is constrained by cytosine methylation", Nat Genet, 20, pp.116~ (1998)
  21. Hermann A, "Biochemistry and biology of mammalian DNA methyltransferases", Cell Mol Life Sci, 61, pp.2571~2587 (2004)
  22. Okano M, "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development", Cell, 99, pp.247~257 (1999)
  23. Gruenbaum Y, "Substrate and sequence specificity of a eukaryotic DNA methylase", Nature, 295, pp.620~ (1982)
  24. Guo JU, "Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain", Nat Neurosci, 17, pp.215~ (2014)
  25. Feng J, "Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons", Nat Neurosci, 13, pp.423~ (2010)
  26. Veldic M, "DNAmethyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains", Proc Natl Acad Sci U S A, 101, pp.348~353 (2004)
  27. Kriaucionis S, "The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain", Science, 324, pp.929~930 (2009)
  28. Tahiliani M, "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1", Science, 324, pp.930~935 (2009)
  29. He YF, "Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA", Science, 333, pp.1303~1307 (2011)
  30. Ito S, "Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine", Science, 333, pp.1300~1303 (2011)
  31. Yu M, "Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome", Cell, 149, pp.1368~1380 (2012)
  32. Zhang L, "Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA", Nat Chem Biol, 8, pp.328~ (2012)
  33. Rai K, "DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45", Cell, 135, pp.1201~1212 (2008)
  34. Bhutani N, "Reprogramming towards pluripotency requires AID-dependent DNA demethylation", Nature, 463, pp.1042~ (2010)
  35. Bhutani N, "DNA demethylation dynamics", Cell, 146, pp.866~872 (2011)
  36. Santiago M, "TET enzymes and DNA hydroxymethylation in neural development and function—how critical are they?", Genomics, 104, pp.334~340 (2014)
  37. Ito S, "Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification", Nature, 466, pp.1129~ (2010)
  38. Dawlaty MM, "Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development", Dev Cell, 24, pp.310~323 (2013)
  39. Portela A, "Epigenetic modifications and human disease", Nat Biotechnol, 28, pp.1057~ (2010)
  40. Heyward FD, "DNA methylation in memory formation : emerging insights", Neuroscientist, 21, pp.475~489 (2015)
  41. Antequera F, "Number of CpG islands and genes in human and mouse", Proc Natl Acad Sci U S A, 90, pp.11995~11999 (1993)
  42. Consortium IHGS, "Initial sequencing and analysis of the human genome", Nature, 409, pp.860~ (2001)
  43. Ioshikhes IP, "Large-scale human promoter mapping using CpG islands", Nat Genet, 26, pp.61~ (2000)
  44. Saxonov S, "A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters", Proc Natl Acad Sci U S A, 103, pp.1412~1417 (2006)
  45. Illingworth R, "A novel CpG island set identifies tissue-specific methylation at developmental gene loci", PLoS Biol, 6, pp.e22~ (2008)
  46. Numata S, "DNA methylation signatures in development and aging of the human prefrontal cortex", Am J Hum Genet, 90, pp.260~272 (2012)
  47. Hernandez DG, "Distinct DNA methylation changes highly correlated with chronological age in the human brain", Hum Mol Genet, 20, pp.1164~1172 (2011)
  48. Horvath S, "Aging effects on DNA methylation modules in human brain and blood tissue", Genome Biol, 13, pp.R97~ (2012)
  49. Heyn H, "Distinct DNA methylomes of newborns and centenarians", Proc Natl Acad Sci U S A, 109, pp.10522~10527 (2012)
  50. Horvath S, "DNA methylation age of human tissues and cell types", Genome Biol, 14, pp.3156~ (2013)
  51. Hannum G, "Genome-wide methylation profiles reveal quantitative views of human aging rates", Mol Cell, 49, pp.359~367 (2013)
  52. 정상은, "DNA methylation-based age prediction from various tissues and body fluids", BMB Reports, 50(11), pp.546~553 (2017), 생화학분자생물학회
  53. Day K, "Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape", Genome Biol, 14, pp.R102~ (2013)
  54. Levine ME, "An epigenetic biomarker of aging for lifespan and healthspan", Aging (Albany NY), 10, pp.573~ (2018)
  55. Horvath S, "DNA methylation-based biomarkers and the epigenetic clock theory of ageing", Nat Rev Genet, 19, pp.371~ (2018)
  56. Horvath S, "The cerebellum ages slowly according to the epigenetic clock", Aging (Albany NY), 7, pp.294~ (2015)
  57. Levine ME, "Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer’s disease related cognitive functioning", Aging (Albany NY), 7, pp.1198~ (2015)
  58. Davies MN, "Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood", Genome Biol, 13, pp.R43~ (2012)
  59. Spiers H, "Methylomic trajectories across human fetal brain development", Genome Res, 25, pp.338~352 (2015)
  60. Lister R, "Global epigenomic reconfiguration during mammalian brain development", Science, 341, pp.1237905~ (2013)
  61. Bakulski KM, "Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex", J Alzheimers Dis, 29, pp.571~588 (2012)
  62. Rao J, "Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients", Transl Psychiatry, 2, pp.e132~ (2012)
  63. Kaut O, "Genome-scale methylation analysis of Parkinson's disease patients'brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1", Neurogenetics, 13, pp.87~91 (2012)
  64. Sanchez-Mut JV, "DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease", Brain, 136, pp.3018~3027 (2013)
  65. Sanchez‐Mut JV, "Promoter hypermethylation of the phosphatase DUSP22 mediates PKA‐dependent TAU phosphorylation and CREB activation in Alzheimer's disease", Hippocampus, 24, pp.363~368 (2014)
  66. Yu L, "Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease", JAMA Neurol, 72, pp.15~24 (2015)
  67. De Jager PL, "Alzheimer's disease : early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci", Nat Neurosci, 17, pp.1156~ (2014)
  68. Lunnon K, "Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease", Nat Neurosci, 17, pp.1164~ (2014)
  69. 배재열, "Synapses in neurodegenerative diseases", BMB Reports, 50(5), pp.237~246 (2017), 생화학분자생물학회
  70. Delgado-Morales R, "Opening up the DNA methylome of dementia", Mol Psychiatry, 22, pp.485~ (2017)
  71. Giri M, "Genes associated with Alzheimer’s disease : an overview and current status", Clin Interv Aging, 11, pp.665~ (2016)
  72. Cho S, "Association of miR-938G> A polymorphisms with primary ovarian insufficiency(POI)-related gene expression", Int J Mol Sci, 18, pp.1255~ (2017)
  73. Lord J, "The epigenetic landscape of Alzheimer's disease", Nat Neurosci, 17, pp.1138~ (2014)
  74. Sanchez-Mut JV, "Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns", Transl Psychiatry, 6, pp.e718~ (2016)
  75. Galpern WR, "Interface between tauopathies and synucleinopathies : a tale of two proteins", Ann Neurol, 59, pp.449~458 (2006)
  76. Lippa CF, "Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease", Ann Neurol, 45, pp.353~357 (1999)
  77. van Eijk KR, "Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects", BMC Genomics, 13, pp.636~ (2012)
  78. Gibbs JR, "Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain", PLoS Genet, 6, pp.e1000952~ (2010)
  79. Chibnik LB, "Alzheimer's loci : epigenetic associations and interaction with genetic factors", Ann Clin Transl Neurol, 2, pp.636~647 (2015)
  80. Kalia LV, "Parkinson's disease", The Lancet, 386, pp.896~912 (2015)
  81. Trinh J, "Advances in the genetics of Parkinson disease", Nat Rev Neurol, 9, pp.445~ (2013)
  82. Consortium IPsDG, "A two-stage meta-analysis identifies several new loci for Parkinson's disease", PLoS Genet, 7, pp.e1002142~ (2011)
  83. Masliah E, "Distinctive patterns of DNA methylation associated with Parkinson disease : identification of concordant epigenetic changes in brain and peripheral blood leukocytes", Epigenetics, 8, pp.1030~1038 (2013)
  84. Nalls MA, "Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease", Nat Genet, 46, pp.989~ (2014)
  85. Belzil VV, "ALS and FTD : an epigenetic perspective", Acta Neuropathol, 132, pp.487~502 (2016)
  86. Ling SC, "Converging mechanisms in ALS and FTD : disrupted RNA and protein homeostasis", Neuron, 79, pp.416~438 (2013)
  87. Liu EY, "C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS", FTD, 2014, pp.128, 525~541
  88. Russ J, "Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier", Acta Neuropathol, 129, pp.39~52 (2015)
  89. Xi Z, "Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients", Hum Mol Genet, 23, pp.5630~5637 (2014)
  90. McColgan P, "Huntington's disease : a clinical review", Eur J Neurol, 25, pp.24~34 (2018)
  91. Bates GP, "Huntington disease", Nat Rev Dis Primers, 1, pp.15005~ (2015)
  92. De Souza RA, "DNA methylation profiling in human Huntington's disease brain", Hum Mol Genet, 25, pp.2013~2030 (2016)
  93. Villar-Menéndez I, "Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A 2A R levels in Huntington’s disease", Neuromolecular Med, 15, pp.295~309 (2013)
  94. Faguy K, "Multiple sclerosis : An update", Radiol Technol, 87, pp.529~550 (2016)
  95. Lindberg RL, "Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS", J Neuroimmunol, 152, pp.154~167 (2004)
  96. Pedre X, "Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions", J Neurosci, 31, pp.3435~3445 (2011)
  97. Mastronardi FG, "Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination : a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation", J Neurosci, 26, pp.11387~11396 (2006)
  98. Huynh JL, "Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains", Nat Neurosci, 17, pp.121~ (2014)

관련 논문AI추천

이 간행물의 다른 논문 (6건)